# Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis

> **NCT03130738** · PHASE2 · COMPLETED · sponsor: **Hill Dermaceuticals, Inc.** · enrollment: 65 (actual)

## Conditions studied

- Otomycosis

## Interventions

- **DRUG:** 7-Day Miconazole Oil (Miconazole 2%)
- **DRUG:** 14-Day Miconazole Oil (Miconazole 2%)
- **DRUG:** 14-Day Placebo - Oil Vehicle

## Key facts

- **NCT ID:** NCT03130738
- **Lead sponsor:** Hill Dermaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-20
- **Primary completion:** 2019-08-06
- **Final completion:** 2019-08-06
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2022-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130738, "Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03130738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*